Mounjaro
tirzepatide
GIP and GLP-1 receptor agonist
Prescription requiredMounjaro vs Wegovy
Understand reviewed ingredients, approved uses, formulations and pharmacy acquisition benchmarks.
Wegovy
semaglutide
GLP-1 receptor agonist
Prescription requiredShared ingredients, classes or uses do not establish interchangeability or identical eligibility.
The key differences
Active ingredients
Wegovy contains semaglutide. Mounjaro contains tirzepatide. A shared ingredient does not establish interchangeability.
Different reviewed classes
Class membership does not establish clinical alternatives.
Approved uses and eligibility
The reviewed uses and their qualifications differ. Shared use concepts do not mean identical eligibility.
How they are taken
Mounjaro: injection, once weekly. Wegovy: injection, once weekly. Wegovy: tablet, once daily. Routine frequency does not describe dose or titration.
Pharmacy acquisition benchmarks
Historical NADAC trends are available within individual products. They are not retail or patient prices and cannot rank these medicines by cost.
At a glance
Active ingredient
Mounjarotirzepatide
Wegovysemaglutide
Medication class
MounjaroGIP and GLP-1 receptor agonist
WegovyGLP-1 receptor agonist
Prescription status
MounjaroPrescription required
WegovyPrescription required
This comparison provides factual information and does not recommend a treatment. Treatment decisions belong with a qualified healthcare professional.
This snapshot does not assess complete contraindications, interactions or adverse effects.